InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (11 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
11
T+90 hit rate
0%
T+90 mean return
-33.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Shah Gaurav, Chief Executive Officer. Director active across 1 company, notably Rocket Pharmaceuticals, INC.. Cumulatively, 21 filings have been published. Breakdown: 3 buys · 11 sells. Total volume traded: €2.2m. History available since 7 February 2022. The latest transaction was disclosed on 13 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
2,728 shares@ US$3.6060.0024% mcap1.2% of flowCommon StockSEC:0001140361-26-021315:0
2,728 shares@ US$3.6060.0024% mcap1.2% of flowCommon StockSEC:0001140361-26-021315
2,253 shares@ US$6.4460.6% of flowCommon StockSEC:0001140361-25-020160:0
3,621 shares@ US$6.5281.0% of flowCommon StockSEC:0001140361-25-019899:0
20,000 shares@ US$5.084.1% of flowCommon StockSEC:0001140361-25-013804:0
Ideal exit: 5 Jan 2026 (T+270)
16,303 shares@ US$10.587.5% of flowCommon StockSEC:0001140361-25-005844:0
81,655 shares0Common StockSEC:0001140361-25-004296:0
11,091 shares@ US$13.0546.2% of flowCommon StockSEC:0001140361-24-047755:0
9,650 shares@ US$18.5047.4% of flowCommon StockSEC:0001140361-24-037932:0
7,979 shares0Common StockSEC:0001140361-24-026878:0
20,272 shares@ US$29.83825.5% of flowCommon StockSEC:0001140361-24-008886:0
46,828 shares0Common StockSEC:0001140361-24-008359:0
7,979 shares0Common StockSEC:0001140361-23-053709:0
4,767 shares@ US$15.4713.1% of flowCommon StockSEC:0001140361-23-040694:0
7,979 shares0Common StockSEC:0001140361-23-039901:0
4,122 shares@ US$21.3753.7% of flowCommon StockSEC:0001140361-23-025742:0
7,979 shares0Common StockSEC:0001140361-23-025133:0
12,194 shares@ US$19.069.9% of flowCommon StockSEC:0001140361-23-008102:0
31,440 shares0Common StockSEC:0001140361-23-008098:0
22,000 shares@ US$17.34150.094% mcap48.8% of flowCommon StockSEC:0001140361-22-004209:0
Ideal exit: 4 Nov 2022 (T+270)
22,000 shares@ US$17.34150.094% mcap97.5% of flowCommon StockSEC:0001140361-22-004209
Ideal exit: 4 Nov 2022 (T+270)
21 of 21 declarations
About Shah Gaurav
Gaurav Shah is the CEO of Rocket Pharmaceuticals, Inc. He leads the company in its strategic and operational activities, focusing on innovation in gene therapies. His expertise in the biopharmaceutical sector is essential for guiding the growth and development of Rocket Pharmaceuticals.
